Cystografin
NDC 0270-0149, diatrizoate meglumine, injection, solution, from BRACCO DIAGNOSTICS INC.
- Product NDC
- 0270-0149
- Status
- Listed
- Labeler
- BRACCO DIAGNOSTICS INC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA010040
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0270-0149 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DIATRIZOATE MEGLUMINE300 mg/mL
Pharmacologic classes
Radiographic Contrast Agent [EPC]; X-Ray Contrast Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0270-0149-57 | 00270014957 | 10 BOTTLE in 1 PACKAGE (0270-0149-57) / 300 mL in 1 BOTTLE |
| 0270-0149-60 | 00270014960 | 10 BOTTLE in 1 PACKAGE (0270-0149-60) / 100 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/7496d736-9f7d-4136-ad5d-b24c7803c21bMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0270-0149
Use it
Look up 0270-0149 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0270-0149 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0270-0149. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.